Pete, here is the info on the FDA meeting:
Pittsburgh, PA - July 17, 1998 - Biocontrol Technology, Inc. (Nasdaq:BICO) announced today that a meeting has been set on Wednesday, August 5, 1998 with high-level officials at the US Food and Drug Administration (FDA) offices regarding its Diasensor(r)1000 noninvasive glucose sensor for diabetics. At the meeting, Biocontrol's medical advisors, senior scientists, and management will update FDA officials on the sensor's development and discuss the data compiled and submitted to gain the recently granted European marketing approval (CE Mark).
Regards, Tom |
